| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/25/2002 | WO2002032642A2 Electroprocessing polymers to form footwear and clothing |
| 04/25/2002 | WO2002032480A2 Microstructures for delivering a composition cutaneously to skin |
| 04/25/2002 | WO2002032461A2 Protein c or activated protein c-like molecules |
| 04/25/2002 | WO2002032457A1 Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10 |
| 04/25/2002 | WO2002032437A1 Preparation and xenotransplantation or porcine islets |
| 04/25/2002 | WO2002032419A2 Methods for modulating bladder function |
| 04/25/2002 | WO2002032397A2 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | WO2002032378A2 Fusion cells and cytokine compositions for treatment of disease |
| 04/25/2002 | WO2002032331A2 Microstructures for treating and conditioning skin |
| 04/25/2002 | WO2002032288A2 Cd38 modulated chemotaxis |
| 04/25/2002 | WO2001098506A3 Methods and means for regulation of gene expression |
| 04/25/2002 | WO2001088136A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2001083740A3 Splice-region antisense composition and method |
| 04/25/2002 | WO2001078754A3 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 04/25/2002 | WO2001075072A3 Production of TcR gamma delta T cells |
| 04/25/2002 | WO2001072782A3 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/25/2002 | WO2001072776A3 Agent and method for reducing intraocular pressure |
| 04/25/2002 | WO2001068907A3 Stable expression of polymorphous forms of human cytochrome P450 2D6 |
| 04/25/2002 | WO2001068880A3 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 04/25/2002 | WO2001061010A3 GTPASE activating proteins |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001059102A3 Nucleozymes with endonuclease activity |
| 04/25/2002 | WO2001055361A3 Recombinant AAV packaging systems |
| 04/25/2002 | WO2001048214A3 METHOD FOR PRODUCING 6-0-α-D-GLUCOPYRANOSYL-D-SORBITE |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | WO2001029193A3 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 04/25/2002 | US20020049997 Methods for producing and transforming cassava protoplasts |
| 04/25/2002 | US20020049995 Nucleic acid encoding GAI gene of arbidopsis thaliana |
| 04/25/2002 | US20020049988 Transgenic animals harboring APP allele having swedish mutation |
| 04/25/2002 | US20020049987 Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof |
| 04/25/2002 | US20020049495 Medical device with coating that promotes endothelial cell adherence |
| 04/25/2002 | US20020049313 Method for introducing foreign material into higher eukaryotic cells |
| 04/25/2002 | US20020049306 Differentiation-suppressive polypeptide |
| 04/25/2002 | US20020049302 Purification of preferential lymphocytes; incubate modulator with cells, detect lymphocytes expressing detectable markers |
| 04/25/2002 | US20020048812 Isolation and in vitro differentiation of conditionally immortalized murine olfactory receptor neurons |
| 04/25/2002 | US20020048801 Peptide with enzymatic activity; for use as diagnostic tools in detecting cancer and cardiovascular and liver disorders |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048785 Novel polypeptides within the tumor necrosis factor receptor superfamily and uses therefor |
| 04/25/2002 | US20020048782 Pyk2 related products and methods |
| 04/25/2002 | US20020048769 Protein-protein interactions in neurodegenerative disorders |
| 04/25/2002 | US20020048764 Human PEM as a target for birth contol and treatment of Alzheimer's disease |
| 04/25/2002 | US20020048746 Model for alzheimer's disease and other neurodegenerative diseases |
| 04/25/2002 | US20020048595 Resorbable extracellular matrix for reconstruction of cartilage tissue |
| 04/25/2002 | US20020048579 Treated tissue or organ can be transplanted in a recipient with reduced risk of graft-versus-host disease. |
| 04/25/2002 | US20020048571 Chimeric polypeptides of serum albumin and uses related thereto |
| 04/25/2002 | US20020048563 Cell paste for tissue regeneration, comprising: (a) one or more cells that naturally secretes one or more biologically active molecules admixed with (b) an extracellular matrix or matrix material |
| 04/25/2002 | US20020048562 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
| 04/25/2002 | DE10050334A1 Composition comprising stem cells and CD6-depleted stem cells, useful for inducing transplant tolerance and for treatment, especially of leukemia, administered separately |
| 04/25/2002 | DE10050091A1 New casein-derived peptide with growth promoting activity, useful as additive for eukaryotic cell cultures and for recombinant protein production |
| 04/25/2002 | DE10049673A1 Enzymatic synthesis of peptide, its mimic or protein, useful e.g. in drug development, using a modified ligase adapted to a particular ester leaving group |
| 04/25/2002 | DE10047951A1 Verfahren zur Stimulation der Paarung von Mikroorganismen in Flüssigmedium Method for stimulating the mating of microorganisms in liquid medium |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464092A1 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | CA2426460A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 04/25/2002 | CA2426403A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2426366A1 Fusion cells and cytokine compositions for treatment of disease |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425927A1 Cytochrome p450 monooxygenases consisting of thermophilic bacteria |
| 04/25/2002 | CA2425763A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | CA2425742A1 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | CA2425727A1 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | CA2425723A1 Neuromedin u delta |
| 04/25/2002 | CA2425669A1 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | CA2425221A1 Protein c or activated protein c-like molecules |
| 04/25/2002 | CA2425174A1 Human gene critical to fertility |
| 04/25/2002 | CA2424643A1 Cd38 modulated chemotaxis |
| 04/24/2002 | EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 04/24/2002 | EP1199366A1 Method for cloning and expression of BSMI Restriction-Modification system in E.coli |
| 04/24/2002 | EP1199365A2 Method for cloning and expression of BpmI restiction endonuclease in E. coli |
| 04/24/2002 | EP1199362A2 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
| 04/24/2002 | EP1199360A2 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor |
| 04/24/2002 | EP1199359A1 Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds |
| 04/24/2002 | EP1199356A2 Highly productive alpha-amylases |
| 04/24/2002 | EP1199354A1 A method of forming a cell pattern on a surface, cellular networks and tissues based thereon |
| 04/24/2002 | EP1198586A1 An in vivo library-versus-library selection of optimized protein-protein interactions |
| 04/24/2002 | EP1198581A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 04/24/2002 | EP1198580A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/24/2002 | EP1198576A1 Sink protein |
| 04/24/2002 | EP1198571A2 Chimeric proteins |
| 04/24/2002 | EP1198570A1 Monomeric protein of the tgf-beta family |
| 04/24/2002 | EP1198569A1 G-protein coupled receptor and dna sequences thereof |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 04/24/2002 | EP1198561A1 Thermostable nucleoside diphosphate kinase for nucleic acid detection |
| 04/24/2002 | EP1198560A2 Mammalian adhesion protease peptides |
| 04/24/2002 | EP1198559A1 Means and methods for nucleic acid transfer |
| 04/24/2002 | EP1198558A1 Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes |
| 04/24/2002 | EP1198557A2 Improved keratinocyte culture and uses thereof |
| 04/24/2002 | EP1198556A2 Methods for producing and preparing cells for cell therapy |
| 04/24/2002 | EP1198488A1 Biodegradable block copolymers with modifiable surface |
| 04/24/2002 | EP1198480A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 04/24/2002 | EP1198475A1 Highly purified cytokine activating factor and methods of use |
| 04/24/2002 | EP1198468A1 Stabilized viral envelope proteins and uses thereof |
| 04/24/2002 | EP1198244A2 Strategy for carbohydrate-based cancer vaccines |
| 04/24/2002 | EP1198240A2 Tissue regenerating agent |
| 04/24/2002 | EP1198238A2 Gene encoding nade, p75ntr -associated cell death executor and uses thereof |